DOI: 10.21202/1993-047X.11.2017.4.146-169

скачать PDF

---

The Failure of Mandated Disclosure, part 4

---

Objective: to elaborate the conceptual theoretical-legal provisions and scientific recommendations for the substantiating the inefficiency of mandated disclosure.

Methods: general dialectic method of cognition, as well as the general scientific and specific legal methods of research, based on it.

Results: the article explores the spectacular prevalence, and failure, of the single most common technique for protecting personal autonomy in modern society: mandated disclosure. The article has four parts: (1) a comprehensive summary of the recurring use of mandated disclosures, in many forms and circumstances,
in the areas of consumer and borrower protection, patient informed consent, contract formation, and constitutional rights; (2) a survey of the empirical literature documenting the failure of the mandated disclosure regime in informing people and in improving their decisions; (3) an account of the multitude of reasons mandated disclosures fail, focusing on the political dynamics underlying the enactments of these mandates, the incentives of disclosers to carry them out, and, most importantly, on the ability of disclosees to use them; and (4) an argument that mandated disclosure not only fails to achieve its stated goal but also leads to unintended consequences that often harm the very people it intends to serve.

Scientific novelty: the article elaborates and introduces into academic sphere the substantiation of the efficiency of mandated disclosure, proves the failure of the mandated disclosure regime in informing people and in improving their decisions, and reveals the unintended consequences that often harm the very people it intends to serve.

Practical significance: the provisions ad conclusions of the article can be used in scientific, law-making and law-enforcement activities, and in the educational process of institutions of higher education.

Keywords :

Constitutional law; Informational law; Civil law; Disclosure; Informed content; Consumer rights protection; Patient rights protection; Borrower rights protection

Bibliography :

1. Rubin E. L. Legislative Methodology: Some Lessons from the Truth-in-Lending Act, Geo. L. J., 1991, vol. 80, pp. 233–234.

2. Miller T. E., Sage W. M. Disclosing physician financial incentives, JAMA, 1999, vol. 281, No. 15, pp. 1424–1430.
3. Sage W. M. Regulating through information: disclosure laws and American health care, Columbia Law Review, 1999, pp. 1701–1829.
4. Krause J. H. Reconceptualizing informed consent in an era of health care cost containment, Iowa L. Rev., 1999, vol. 85, pp. 261.
5. Craswell R. Taking information seriously: Misrepresentation and nondisclosure in contract law and elsewhere, Virginia Law Review, 2006, vol. 92, pp. 565–632.
6. Craswell R. Property Rules and Liability Rules in Unconscionability and Related Doctrines, The University of Chicago Law Review, 1993, vol. 60, No. 1, pp. 1–65.
7. Rubin E. L. Toward a General Theory of Waiver, UCLA L. Rev., 1980, vol. 28, pp. 478.
8. Schneider C. E., Hall M. A. The Patient Life: Can Consumers Direct Health Care?, American Journal of Law & Medicine, 2009, vol. 35, No. 1, pp. 7–65.
9. Pear R. Bush Proposes Linking the Medicare Drug Premium to Beneficiaries› Income, N.Y. Times, Feb. 16, 2008, pp. A15.
10. Colb S. F. The Supreme Court Holds that Responding to Police Interrogation Waives the Right to Remain Silent, FINDLAW, June 7, 2010, available at: http://writ.news.findlaw.com/colb/20100607.html
11. Beales H., Craswell R., Salop S. C. The efficient regulation of consumer information, The Journal of Law and Economics, 1981, vol. 24, No. 3, pp. 491–539.
12. Mitford J. The American way of death revisited, Vintage, 2000.
13. Chang Y.-C. R., Sherman H. Consumer credit search behaviour, International Journal of Consumer Studies, 1992, vol. 16, No. 3, pp. 207–227.
14. McAlexander J. H., Scammon D. L. Are disclosures sufficient? A micro analysis of impact in the financial services market, Journal of Public Policy & Marketing, 1988, No. 7, pp. 185–202.

15. Brandt W. K., Day G. S. Information Disclosure and Consumer Behavior: An Empirical Evaluation of Truth-in-Lending, U. Mich. JL Reform, 1973, vol. 7, p. 297.
16. Willis L. E. Decisionmaking and the limits of disclosure: The problem of predatory lending: Price, Md. L. Rev., 2006, vol. 65, p. 707.
17. Lee J., Hogarth J. M. The price of money: Consumers› understanding of APRs and contract interest rates, Journal of Public Policy & Marketing, 1999, No. 18, pp. 66–76.
18. Kinsey J., McAlister R. Consumer Knowledge of the Costs of Open-end Credit, Journal of Consumer Affairs, 1981, vol. 15, No. 2, pp. 249–270.
19. Shaffer S. l. The competitive impact of disclosure requirements in the credit card industry, Journal of Regulatory Economics, 1999, vol. 15, No. 2, pp. 183–198.
20. Willis L. E. Against Financial-Literacy Education, Iowa L. Rev., 2008, vol. 197, No. 94.
21. Holzer J. Geithner: New Bureau To Focus On Improved Disclosures, Foxbusiness, Sept. 21, 2010, available at: http://www.foxbusiness.com/markets/2010/09/21/geithner-new-bureau-focus-improved-disclosures
22. Schneider C. E. After Autonomy, Wake Forest L. Rev., 2006, vol. 411, No. 41, pp. 417–425.
23. Schneider C. E. The practice of autonomy: patients, doctors, and medical decisions, Oxford University Press on Demand, 1998.
24. Garrison M., Schneider C. E. The law of bioethics: individual autonomy and social regulation, 2nd ed., 2009.
25. Braddock I., Clarence H., Edwards K. A., Hasenberg N. M., Laidley T. L., Levinson W. Informed decision making in outpatient practice: time to get back to basics, Jama, 1999, vol. 282, No. 24, pp. 2313–2320.
26. Paasche-Orlow M. K., Taylor H. A., Brancati F. L. Readability standards for informed-consent forms as compared with actual readability, New England Journal of Medicine, 2003, vol. 348, No. 8, pp. 721–726.
27. Schwarze M. L., Sayla M. A., Alexander G. C. Exploring patient preferences for infrainguinal bypass operation, Journal of the American College of Surgeons, 2006, vol. 202, No. 3, pp. 445–452.
28. Herz D. A., Looman J. E., Lewis S. K. Informed consent: is it a myth?, Neurosurgery, 1992, vol. 30, No. 3, pp. 453–458.
29. Fagerlin A., Lakhani I., Lantz P. M., Janz N. K., Morrow M., Schwartz K., Deapen D., Salem B., Liu L., Katz S. J. An
informed decision?: Breast cancer patients and their knowledge about treatment, Patient education and counseling, 2006, vol. 64, No. 1, pp. 303–312.
30. Appelbaum P. S., Lidz C. W., Meisel A. Informed consent: Legal theory and clinical practice, 1987.
31. Faden R. R., Becker C., Lewis C., Freeman J., Faden A. I. Disclosure of information to patients in medical care, Medical Care, 1981, vol. 19, pp. 718–733.
32. Hall M. A., Dugan E., Balkrishnan R., Bradley D. How disclosing HMO physician incentives affects trust, Health Affairs, 2002, vol. 21, No. 2, pp. 197–206.
33. Nattinger A. B., Hoffmann R. G., Shapiro R., Gottlieb M. S., Goodwin J. S. The effect of legislative requirements on the use of breast-conserving surgery, New England Journal of Medicine, 1996, vol. 335, No. 14, pp. 1035–1041.
34. Joffe S., Cook E. F., Cleary P. D., Clark J. W., Weeks J. C. Quality of informed consent in cancer clinical trials: a crosssectional survey, The Lancet, 2001, vol. 358, No. 9295, pp. 1772–1777.
35. Geller G., Strauss M., Bernhardt B. A., Holtzman N. A. “Decoding” Informed Consent: Insights from Women regarding Breast Cancer Susceptibility Testing, Hastings Center Report, 1997, vol. 27, No. 2, pp. 28–33.
36. Magid L. It pays to read license agreements, PC Pitstop, 2008, available at: http:// pcpitstop.com/spycheck/eula.asp (access date: 15.11.2010).
37. Bakos Y.-N., Trossen D. R. Does Anyone Read the Fine Print? Testing a Law and Economics Approach to Standard Form Contracts, N.Y. Univ. Sch. of Law Law & Econ. Working Paper Grp., 2009, available at: http://lsr.nellco.org/nyu_lewp/195/
38. Hillman R. A. Online Consumer Standard Form Contracting Practices: A Survey and Discussion of Legal Implications, Consumer Protection in the Age of the›information Economy / ed. Winn J. K., Routledge, 2006.
39. Marotta-Wurgler F. Will Increased Disclosure Help? Evaluating the Recommendations of the ALI's «Principles of the Law of Software Contracts», The University of Chicago Law Review, 2011, available at: http://www.law.uchicago.edu/files/file/Wurgler paper.pdf
40. Fagerlin A., Schneider C. E. Enough: the failure of the living will, Hastings Center Report, 2004, vol. 34, No. 2, pp. 30–42.
41. Pope T. M. The maladaptation of Miranda to advance directives: a critique of the implementation of the Patient Self-Determination Act, Health Matrix, 1999, vol. 9, pp. 139.
42. Dresser R. Confronting the ‹Near Irrelevance› of Advance Directives, J. Clinical Ethics, 1994, No. 5, pp. 55–56.
43. Marshall M. N., Shekelle P. G., Leatherman S., Brook R. H. The public release of performance data: what do we expect to gain? A review of the evidence, Jama, 2000, vol. 283, No. 14, pp. 1866–1874.
44. Schneider E. C., Epstein A. M. Use of public performance reports: a survey of patients undergoing cardiac surgery, Jama, 1998, vol. 279, No. 20, pp. 1638–1642.

45. Epstein A. M. Rolling down the runway: the challenges ahead for quality report cards, Jama, 1998, vol. 279, No. 21, pp. 1691–1696.
46. Hibbard J. H., Jewett J. J., Engelmann S., Tusler M. Can Medicare beneficiaries make informed choices?, Health Affairs, 1998, vol. 17, No. 6, pp. 181–193.
47. Lubalin J. S., Harris-Kojetin L. D. What do consumers want and need to know in making health care choices?, Medical Care Research and Review, 1999, vol. 56, No. 1_suppl., pp. 67–102.
48. Hibbard J. H., Jewett J. J., Legnini M. W., Tusler M. Choosing a health plan: do large employers use the data?, Health Affairs, 1997, vol. 16, No. 6, pp. 172–180.
49. Hannan E. L., Kilburn H., Racz M., Shields E., Chassin M. R. Improving the outcomes of coronary artery bypass surgery in New York State, Jama, 1994, vol. 271, No. 10, pp. 761–766.
50. Mukamel D. B., Mushlin A. I. Quality of care information makes a difference: an analysis of market share and price changes after publication of the New York State Cardiac Surgery Mortality Reports, Medical care, 1998, vol. 36, No. 7, pp. 945–954.
51. Peterson E. D., DeLong E. R., Jollis J. G., Muhlbaier L. H., Mark D. B. The effects of New York’s bypass surgery provider profiling on access to care and patient outcomes in the elderly, Journal of the American College of Cardiology, 1998, vol. 32, No. 4, pp. 993–999.
52. Green J., Wintfeld N. Report cards on cardiac surgeons – assessing New York state›s approach, New Eng. J. Med., 1995, vol. 332.
53. Hofer T. P., Hayward R. A., Greenfield S., Wagner E. H., Kaplan S. H., Manning W. G. The unreliability of individual physician report cards for assessing the costs and quality of care of a chronic disease, Jama, 1999, vol. 281, No. 22, pp. 2098–2105.
54. Lu S. F. Multitasking, Information Disclosure and Product Quality: Evidence from Nursing Homes 1-3, Simon Sch. Working Paper, 2009, available at: http://ssrn.com/abstract=1340578
55. Dranove D., Kessler D., McClellan M., Satterthwaite M. Is more information better? The effects of “report cards” on health care providers, Journal of political Economy, 2003, vol. 111, No. 3, pp. 555–588.
56. Dafny L., Dranove D. Do report cards tell consumers anything they don›t already know? The case of Medicare HMOs, The Rand journal of economics, 2008, vol. 39, No. 3, pp. 790–821.
57. Walfish S., Watkins K. M. Readability level of health insurance portability and accountability act notices of privacy practices utilized by academic medical centers, Evaluation & the health professions, 2005, vol. 28, No. 4, pp. 479–486.
58. Hochhauser M. Readability of HIPAA privacy notices, BENEFITSLINK.COM., 2003, available at: http://benefitslink.com/articles/hipaareadability.pdf.
59. Schneider C. E. HIPAA-cracy, Hasting Center Rep. T., Jan. – Feb. 2006, pp. 10, 11.
60. Fogg B. J. at al. How Do People Evaluate a Web Site›s Credibility? Results from a Large Study, Consumer Reports WebWatch, available at: http://www.consumerwebwatch.org/pdfs/stanfordPTL.pdf.
61. Mathios A. D. The impact of mandatory disclosure laws on product choices: An analysis of the salad dressing market, The Journal of Law and Economics, 2000, vol. 43, No. 2, pp. 651–678.
62. Jones G., Richardson M. An objective examination of consumer perception of nutrition information based on healthiness ratings and eye movements, Public health nutrition, 2007, vol. 10, No. 03, pp. 238–244.
63. Cowburn G., Stockley L. Consumer understanding and use of nutrition labelling: a systematic review, Public health nutrition, 2005, vol. 8, No. 1, pp. 21–28.
64. Rothman R. L., Housam R., Weiss H., Davis D., Gregory R., Gebretsadik T., Shintani A., Elasy T. A. Patient understanding of food labels: the role of literacy and numeracy, American journal of preventive medicine, 2006, vol. 31, No. 5, pp. 391–398.
65. Huizinga M. M., Carlisle A. J., Cavanaugh K. L., Davis D. L., Gregory R. P., Schlundt D. G., Rothman R. L. Literacy, numeracy, and portion-size estimation skills, American journal of preventive medicine, 2009, vol. 36, No. 4, pp. 324–328.
66. Ippolito P. M. Advertising nutrition & health: evidence from food advertising, 1977–1997, DIANE Publishing, 2002.
67. Ippolito P. M., Mathios A. D. Information, advertising, and health choices: a study of the cereal market, Rand J. Econ., 1990, vol. 21, pp. 211–246.
68. Ippolito P. M., Mathios A. D. Information and advertising: The case of fat consumption in the United States, The American Economic Review, 1995, vol. 85, No. 2, pp. 91–95.
69. Derby B. M., Levy A. S. Do Food Labels Work?, Handbook of marketing and society, 2001, pp. 372–383.
70. Putler D. S., Frazao E. Assessing the effects of diet/health awareness on the consumption and composition of fat intake, Economics of Food Safety / ed. J. A. Caswell, 1991, pp. 247–270.
71. Rogers R. A little knowledge is a dangerous thing... Emerging Miranda research and professional roles for psychologists, American Psychologist, 2008, vol. 63, No. 8, p. 776.
72. Leo R. A. Questioning the relevance of Miranda in the twenty-first century, Michigan law review, 2001, vol. 99, No. 5, pp. 1000–1029.

73. Malone P. A. You Have the Right to Remain Silent: «Miranda» After Twenty Years, The American Scholar, 1986, pp. 367–380.
74. Griffiths J., Ayres R. E. A Postscript to the Miranda Project: Interrogation of Draft Protestors, The Yale Law Journal, 1967, vol. 77, No. 2, pp. 300–319.
75. McNeil K., Nevin J. R., Trubek D. M., Miller R. E. Market discrimination against the poor and the impact of consumer disclosure laws: The used car industry, Law and Society Review, 1979, pp. 695–720.
76. Fung A., Graham M., Weil D. Full disclosure: The perils and promise of transparency, Cambridge University Press, 2007.
77. Winston C. The Efficacy of information policy: A review of Archon Fung, Mary Graham, and David Weil's full disclosure: The perils and promise of transparency, Journal of Economic Literature, 2008, vol. 46, No. 3, pp. 704–717.
78. Bardach E., Kagan R. A. Going by the book: The problem of regulatory unreasonableness, 2nd ed., Transaction Publishers, 2003.
79. Wilson R. F. Estate of Gelsinger v. Trustees of University of Pennsylvania: Money, prestige, and conflicts of interest in human subjects research, Health law and bioethics, ed. S. H. Johnson et al., 2009.
80. Weinfurt K. P., Friedman J. Y., Dinan M. A., Allsbrook J. S., Hall M. A., Dhillon J. K., Sugarman J. Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators, The Journal of Law, Medicine & Ethics, 2006, vol. 34, No. 3, pp. 581–591.
81. Camerer C., Issacharoff S., Loewenstein G., O'donoghue T., Rabin M. Regulation for Conservatives: Behavioral Economics and the Case for «Asymmetric Paternalism», University of Pennsylvania Law Review, 2003, vol. 151, No. 3, pp. 1211–1254.
82. Sunstein C. R., Thaler R. H. Libertarian paternalism is not an oxymoron, The University of Chicago Law Review, 2003, pp. 1159–1202.
83. McCloskey E. The Patient Self-Determination Act, Kennedy Institute of Ethics Journal, 1991, No. 1.
84. Hall M. A. When patients say no (to save money): an essay on the tectonics of health law, Conn. L. Rev., 2008, vol. 41, pp. 743.
85. Engel K. C., McCoy P. A. A tale of three markets: The law and economics of predatory lending, Tex. L. Rev., 2001, vol. 80, p. 1255.
86. Pottow J. A. Private liability for reckless consumer lending, U. Ill. L. Rev., 2007, p. 405.
87. Financial regulatory reform: a new foundation, U.S. DEP'T OF THE TREASURY, 2009, available at: http://www.
financialstability.gov/docs/regs/FinalReport_web.pdf
88. Bar-Gill O. The law, economics and psychology of subprime mortgage contracts, Cornell L. Rev., 2008, vol. 94, p. 1073.
89. Renuart E., Thompson D. E. The Truth, the Whole Truth, and Nothing but the Truth: Fulfilling the Promise of Truth in Lending, Yale J. on Reg., 2008, vol. 25, p. 181.
90. Freeman J. The Good Driller Award, Op-Ed., N.Y. Times, July 1, 2010, p. A31.
91. Sugarman J., Powe N. R., Brillantes D. A., Smith M. K. The cost of ethics legislation: A look at the Patient Self-Determination Act, Kennedy Institute of Ethics Journal, 1993, vol. 3, No. 4, pp. 387–399.
92. Jordan R. L., Warren W. D. Disclosure of Finance Charges: A Rationale, Michigan Law Review, 1966, vol. 64, No. 7, pp. 1285–1322.
93. Kripke H. Gesture and Reality in Consumer Credit Reform, NYUL Rev., 1969, vol. 44, p. 1.
94. Fishman M. J., Hagerty K. M. Mandatory Disclosure, The new Palgrave dictionary of economics and the law, ed. P. Newman, 1998.
95. Grossman S. J. The informational role of warranties and private disclosure about product quality, The Journal of Law and Economics, 1981, vol. 24, No. 3, pp. 461–483.
96. Polinsky A. M., Shavell S. Mandatory versus voluntary disclosure of product risks, Stanford Law and Econ. Olin Working Paper, 2006, available at: http://ssrn.com/ abstract=939546.
97. Eskridge Jr W. N. One Hundred Years of Ineptitude: The Need for Mortgage Rules Consonant with the Economic and Psychological Dynamics of the Home Sale and Loan Transaction, Virginia Law Review, 1984, pp. 1083–1218.
98. Saver R. S. Medical research oversight from the corporate governance perspective: Comparing institutional review boards and corporate boards, Wm. & Mary L. Rev., 2004, vol. 46, p. 619.
99. Stark D. P., Choplin J. M. A cognitive and social psychological analysis of disclosure laws and call for mortgage counseling to prevent predatory lending, Psychology, Public Policy, and Law, 2010, vol. 16, No. 1, p. 85.
100. Ziegler D. K., Mosier M. C., Buenaver M., Okuyemi K. How much information about adverse effects of medication do patients want from physicians?, Archives of internal medicine, 2001, vol. 161, No. 5, pp. 706–713.
101. Hibbard J. H., Slovic P., Jewett J. J. Informing consumer decisions in health care: implications from decision-making research, The Milbank Quarterly, 1997, vol. 75, No. 3, pp. 395–414.
102. Lemaire R. Informed consent – a contemporary myth?, Bone & Joint Journal, 2006, vol. 88, No. 1, pp. 2–7.
103. Grady C., Horstmann E., Sussman J. S., Hull S. C. The limits of disclosure: what research subjects want to know about investigator financial interests, The Journal of Law, Medicine & Ethics, 2006, vol. 34, No. 3, pp. 592–599.
104. Latin H. Good warnings, bad products, and cognitive limitations, Ucla L. Rev., 1993, vol. 41, p. 1193.
105. Miller G. The magical number seven, plus or minus two: Some limits on our capacity for processing information, Psychological Review, 1956, vol. 63, No. 2, pp. 81–97.

106. Sandberg E. H., et a. Clinicians Consistently Exceed a Typical Person's Short- Term Memory During Preoperative Teaching, Surv. Anesthesiology, 2009, vol. 53, p. 131.
107. Schneider C. E. The Hydra, Hastings Center Report, July – Aug., 2010, p. 9.
108. Albala I., Doyle M., Appelbaum P. S. The evolution of consent forms for research: a quarter century of changes, IRB: Ethics & Human Research, 2010, vol. 32, No. 3, pp. 7–11.
109. Beardsley E., Jefford M., Mileshkin L. Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening?, Journal of Clinical Oncology, 2007, available at: http://jco.ascopubs.org/content/25/9/e13.full.pdf.
110. Burman W., Breese P., Weis S., Bock N., Bernardo J., Vernon A., Consortium T. T. The effects of local review on informed consent documents from a multicenter clinical trials consortium, Controlled clinical trials, 2003, vol. 24, No. 3, pp. 245–255.
111. Waltz J. R., Scheuneman T. W. Informed consent to therapy, Nw. UL Rev., 1969, vol. 64, p. 628.
112. Cryer B. NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality, Am. J. Gastroenterol., 2005, vol. 100, No. 8, pp. 1694–1695.
113. Boyd N. F., Sutherland H. J., Heasman K. Z., Tritchler D. L., Cummings B. J. Whose utilities for decision analysis?, Medical Decision Making, 1990, vol. 10, No. 1, pp. 58–67.
114. Ubel P. A., Loewenstein G., Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public, Quality of life Research, 2003, vol. 12, No. 6, pp. 599–607.
115. Brown L. D. Management by objection? Public policies to protect choice in health plans, Medical care research and review, 1999, vol. 56, No. suppl 1, pp. 145–165.
116. Green L. A., Lowery J. C., Kowalski C. P., Wyszewianski L. Impact of institutional review board practice variation on observational health services research, Health services research, 2006, vol. 41, No. 1, pp. 214–230.
117. Humphreys K., Trafton J., Wagner T. H. The cost of institutional review board procedures in multicenter observational research, Annals of internal medicine, 2003, vol. 139, No. 1, p. 77.
118. Wendler D., Rackoff J. Consent for continuing research participation: what is it and when should it be obtained?, IRB: Ethics & Human Res., May – June 2002, p. 1.
119. Woloshin K. K., Ruffin M., Gorenflo D. W. Patients' interpretation of qualitative probability statements, Archives of family medicine, 1994, vol. 3, No. 11, pp. 961–966.
120. Berry D. C., Raynor D., Knapp P., Bersellini E. Patients’ understanding of risk associated with medication use, Drug Safety, 2003, vol. 26, No. 1, pp. 1–11.
121. Bryant G. D., Norman G. R. Expressions of probability: words and numbers, The New England Journal of Medicine, 1980, vol. 302, No. 7, p. 411.
122. Timmermans D. The roles of experience and domain of expertise in using numerical and verbal probability terms in medical decisions, Medical Decision Making, 1994, vol. 14, No. 2, pp. 146–156.
123. Smits T., Hoorens V. How probable is probably? It depends on whom you›re talking about, Journal of Behavioral Decision Making, 2005, vol. 18, No. 2, p. 83.
124. Grimes D. A., Snively G. R. Patients' understanding of medical risks: implications for genetic counseling, Obstetrics & Gynecology, 1999, vol. 93, No. 6, pp. 910–914.
125. Knapp P., Raynor D. K., Woolf E., Gardner P. H., Carrigan N., McMillan B. Communicating the risk of side effects to patients, Drug Safety, 2009, vol. 32, No. 10, pp. 837–849.
126. Moxey A., O’Connell D., McGettigan P., Henry D. Describing treatment effects to patients, Journal of General Internal Medicine, 2003, vol. 18, No. 11, pp. 948–959.
127. Marotta-Wurgler F. Are “Pay Now, Terms Later” Contracts Worse for Buyers? Evidence from Software License Agreements, The Journal of Legal Studies, 2009, vol. 38, No. 2, pp. 309–343.
128. Kenneth J. Arrow, Uncertainty and the Welfare Economics of Medical Care, 53 Am, Econ. Rev., 1963, vol. 941, pp. 947–965.
129. Yarnall K. S., Pollak K. I., Østbye T., Krause K. M., Michener J. L. Primary care: is there enough time for prevention?, American journal of public health, 2003, vol. 93, No. 4, pp. 635–641.
130. Østbye T., Yarnall K. S., Krause K. M., Pollak K. I., Gradison M., Michener J. L. Is there time for management of patients with chronic diseases in primary care?, The Annals of Family Medicine, 2005, vol. 3, No. 3, pp. 209–214.
131. Morris L. S., Schulz R. Patient compliance – an overview, Journal of clinical pharmacy and therapeutics, 1992, vol. 17, No. 5, pp. 283–295.
132. Eraker S. A., Kirscht J. P., Becker M. H. Understanding and improving patient compliance, Annals of internal medicine, 1984, vol. 100, No. 2, pp. 258–268.
133. Berthelot J.-M., Glemarec J., Guillot P., Chiffoleau A., Maugars Y., Rodat O. Informing patients about serious side effects of drugs. A 2001 survey of 341 French rheumatologists, Joint Bone Spine, 2003, vol. 70, No. 1, pp. 52–57.

134. Ubel P. A. Truth in the most optimistic way, Annals of internal medicine, 2001,vol. 134, No. 12, pp. 1142–1143.
135. Robinson T. M., Alexander S. C., Hays M., Jeffreys A. S., Olsen M. K., Rodriguez K. L., Pollak K. I., Abernethy A. P., Arnold R., Tulsky J. A. Patient–oncologist communication in advanced cancer: predictors of patient perception of prognosis, Supportive Care in Cancer, 2008, vol. 16, No. 9, pp. 1049–1057.
136. Carrigan N., Raynor D., Knapp P. Adequacy of patient information on adverse effects, Drug Safety, 2008, vol. 31, No. 4, pp. 305–312.
137. Hall M. A. The theory and practice of disclosing HMO physician incentives, Law and Contemporary Problems, 2002, vol. 65, No. 4, pp. 207–239.
138. Scott J. C. Seeing like a state: How certain schemes to improve the human condition have failed, Yale University Press, 1998.
139. Block-Lieb S., Janger E. J. The Myth of the Rational Borrower: Rationality, Behavioralism, and the Misguided Reform of Bankruptcy Law, Tex. L. Rev., 2005, vol. 84, p. 1481.
140. Cain D. M., Loewenstein G., Moore D. A. The dirt on coming clean: Perverse effects of disclosing conflicts of interest, The Journal of Legal Studies, 2005, vol. 34, No. 1, pp. 1–25.
141. Nehf J. P. Effective Regulation of Rent-to-Own Contracts, OHIO ST. L.J., 1991, vol. 52.
142. Lipka S. Do crime statistics keep students safe, Chronicle of Higher Education, 2009, vol. 55, No. 21, pp. A1–A17.
143. Tu T. H., Lauer J. R. Word of mouth and physician referrals still drive health care provider choice, Center for Studying Health System Change Washington, DC, 2008, available at: http://www.hschange.org/CONTENT/1028/1028.pdf.
144. Tu H. T., May J. H. Self-pay markets in health care: consumer nirvana or caveat emptor?, Health Affairs, 2007, available at: http://content.healthaffairs.org/cgi/content/reprint/26/2/w217.
145. Choi S. J. 8c AC Pritchard, Behavioral Economics and the SEC, Stan. L. REV., 2003, vol. 56, No. 1, pp. 16–45.
146. Fischer G. S., Tulsky J. A., Rose M. R., Siminoff L. A., Arnold R. M. Patient knowledge and physician predictions of treatment preferences after discussion of advance directives, Journal of general internal medicine, 1998, vol. 13, No. 7, pp. 447–454.
147. Hoc A. Committee on Health Literacy for the American Council on Scientific Affairs, American Medical Association. Health literacy: Report of the council on scientific affairs, Jama, 1999, vol. 281, No. 6, pp. 552–557.
148. Kirsch I. S. Adult literacy in America: A first look at the results of the National Adult Literacy Survey, ERIC, 1993.
149. Williams M. V., Parker R. M., Baker D. W., Parikh N. S., Pitkin K., Coates W. C., Nurss J. R. Inadequate functional health literacy among patients at two public hospitals, Jama, 1995, vol. 274, No. 21, pp. 1677–1682.
150. Heisler M. Helping your patients with chronic disease: Effective physician approaches to support self-management, Seminars Med. Prac., 2005, vol. 8.
151. Schwartz L. M., Woloshin S., Black W. C., Welch H. G. The role of numeracy in understanding the benefit of screening mammography, Annals of internal medicine, 1997, vol. 127, No. 11, pp. 966–972.
152. Lipkus I. M., Samsa G., Rimer B. K. General performance on a numeracy scale among highly educated samples, Medical decision making, 2001, vol. 21, No. 1, pp. 37–44.
153. Hochhauser M. Lost in the fine print: Readability of financial privacy notices, Privacy Rights Clearinghouse, 2001, available at: http://www.privacyrights.org/ar/GLB-Reading.htm.
154. Hibbard J. H., Jewett J. J. Will quality report cards help consumers?, Health Affairs, 1997, vol. 16, No. 3, pp. 218–228.
155. Breese P., Burman W., Rietmeijer C., Lezotte D. The Health Insurance Portability and Accountability Act and the informed consent process, Annals of internal medicine, 2004, vol. 141, No. 11, pp. 897–898.
156. Breese P., Burman W. Readability of notice of privacy forms used by major health care institutions, Jama, 2005, vol. 293, No. 13, pp. 1588–1594.
157. White A. M., Mansfield C. L. Literacy and Contract, Stan. L. & Pol'y Rev., 2002, vol. 13, p. 233.
158. Eisenberg M. A. Text Anxiety, Cal. L. Rev., 1986, vol. 59 S, p. 305.
159. Holmes-Rovner M., Stableford S., Fagerlin A., Wei J. T., Dunn R. L., Ohene-Frempong J., Kelly-Blake K., Rovner D. R. Evidence-based patient choice: a prostate cancer decision aid in plain language, BMC Medical Informatics and Decision Making, 2005, available at: http://www.biomedcentral.com/1472-6947/5/16
160. Beshears J., Choi J. J., Laibson D., Madrian B. C. How Does Simplified Disclosure Affect Individuals' Mutual Fund Choices?, Working Paper, 2009, available at: http://www.nber.org/papers/w14859.
161. Levine R. J. Letter, IRB: ETHICS & HUMAN RES., Jan. 1982, p. 8.
162. Ferguson A. B., Douglas A. C. A study of juvenile waiver, San Diego L. Rev., 1970, vol. 7, p. 39.
163. Virmani J., Schneiderman L. J., Kaplan R. M. Relationship of advance directives to physician-patient communication, Archives of Internal Medicine, 1994, vol. 154, No. 8, pp. 909–913.
164. Tulsky J. A., Fischer G. S., Rose M. R., Arnold R. M. Opening the black box: how do physicians communicate about advance directives?, Annals of Internal Medicine, 1998, vol. 129, No. 6, pp. 441–449.

165. Fitten L. J., Waite M. S. Impact of medical hospitalization on treatment decision-making capacity in the elderly, Archives of Internal Medicine, 1990, vol. 150, No. 8, pp. 1717–1721.
166. Gottfredson L. S., Deary I. J. Intelligence predicts health and longevity, but why?, Current Directions in Psychological Science, 2004, vol. 13, No. 1, pp. 1–4.
167. Nisbett R. E., Ross L. Human inference: Strategies and shortcomings of social judgment, 1980.
168. Diem S. J., Lantos J. D., Tulsky J. A. Cardiopulmonary resuscitation on television – miracles and misinformation, New England Journal of Medicine, 1996, vol. 334, No. 24, pp. 1578–1582.
169. Dresser R. The ubiquity and utility of the therapeutic misconception, Social philosophy and policy, 2002, vol. 19, No. 02, pp. 271–294.
170. Lacko J. M., Pappalardo J. K. The failure and promise of mandated consumer mortgage disclosures: Evidence from qualitative interviews and a controlled experiment with mortgage borrowers, The American Economic Review, 2010, vol. 100, No. 2, pp. 516–521.
171. Sage W. M. Accountability through information: What the health care industry can learn from securities regulation, Milbank Memorial Fund., 2000, available at: http://www.milbank.org/reports/0012sage.html.
172. Cooper B. S. From bill-payer to purchaser: Medicare in transition, Health systems review, 1997, vol. 30, No. 4, p. 16.
173. Schwarcz D. Beyond disclosure: The case for banning contingent commissions, Yale L. & Pol'y Rev., 2006, vol. 25, p. 289.
174. Ellsworth P. C. Are twelve heads better than one?, Law and Contemporary Problems, 1989, vol. 52, No. 4, pp. 205–224.
175. Hanoch Y., Rice T. Can limiting choice increase social welfare? The elderly and health insurance, Milbank Quarterly, 2006, vol. 84, No. 1, pp. 37–73.
176. Lacko J. M., Pappalardo J. K. The effect of mortgage broker compensation disclosures on consumers and competition: A controlled experiment, 2004.
177. Pierce P. F. Deciding on breast cancer treatment: a description of decision behavior, Nursing research, 1993, vol. 42, No. 1, pp. 22–28.
178. Gilbert D. Stumbling on happiness, New York: Knopf, 2006.
179. Wilson T. D. Strangers to ourselves: discovering the adaptive unconscious, 2002.
180. Bar-Gill O. Informing consumers about themselves, N.Y. Univ. Sch. of Law Ctr. for Law and Econ., Working Paper, 2007, available at: http://ssrn.com/abstract=1056381.
181. Gilbert D. T., Wilson T. D. Miswanting: Some problems in the forecasting of future affective states, 2000.
182. Forgas J. P. Feeling and thinking: The role of affect in social cognition, Cambridge University Press, 2001.
183. Ausubel L. M. The failure of competition in the credit card market, The American Economic Review, 1991, pp. 50–81.
184. Vigna S. D., Malmendier U. Paying not to go to the gym, The American Economic Review, 2006, vol. 96, No. 3, pp. 694–719.
185. Tsevat J., Sherman S. N., McElwee J. A., Mandell K. L., Simbartl L. A., Sonnenberg F. A., Fowler Jr F. J. The will to live among HIV-infected patients, Annals of internal medicine, 1999, vol. 131, No. 3, pp. 194–198.
186. Schon D. The Reflective Practitioner, New York: Basic Books, 1983.
187. Klein G. A. Sources of power, 1998.
188. Marglin S. A. Towards the Decolonization of the Mind, Dominating knowledge: Development, culture, and resistance, 1990, pp. 1–28.
189. Charles C., Whelan T., Gafni A. What do we mean by partnership in making decisions about treatment?, BMJ: British Medical Journal, 1999, vol. 319, No. 7212, p. 780.
190. Ende J., Kazis L., Ash A., Moskowitz M. A. Measuring patients’ desire for autonomy, Journal of general internal medicine, 1989, vol. 4, No. 1, pp. 23–30.
191. Choi J. J., Laibson D., Madrian B. C., Metrick A. For better or for worse: Default effects and 401 (k) savings behavior, Perspectives on the Economics of Aging, ed. D. A. Wise, University of Chicago Press, 2004, pp. 81–126.
192. Choi J. J., et al. Optimal defaults, Am. Econ. Rev., 2003, vol. 93, No. 2.
193. Helman R., Salisbury D. L., Paladino V., Copeland C. Encouraging workers to save: The 2005 retirement confidence survey, 2005.
194. Choi J. J., Laibson D., Madrian B. C., Metrick A. Defined contribution pensions: Plan rules, participant choices, and the path of least resistance, Tax policy and the economy, 2002, vol. 16, pp. 67–113.
195. Choi J. J., Laibson D. I., Madrian B. C. Are empowerment and education enough? Underdiversification in 401 (k) plans, Brookings papers on economic activity, 2005, No. 2, pp. 151–213.
196. Schwartz A., Wilde L. L. Intervening in markets on the basis of imperfect information: A legal and economic analysis, U. Pa. L. Rev., 1978, vol. 127, p. 630.
197. Priest G. L. A theory of the consumer product warranty, The Yale Law Journal, 1981, vol. 90, No. 6, pp. 1297–1352.

198. Gillette C. P. Rolling contracts as an agency problem, Wis. L. Rev., 2004, p. 679.
199. Gilo D., Porat A. The Unconventional Uses of Transactions Costs, Boilerplate: The Foundation of Market Contracts, ed. O. Ben-Shahar, Cambridge University Press, 2007.
200. Kapp M. B. Patient Autonomy in the Age of Consumer-Driven Health Care: Informed Consent and Informed Choice, J. Health & Biomedical L., 2006, vol. 2.
201. Giamatti A. Bartlett: A Free and Ordered Space: The Real World of the University, Nueva York, WW Norton, 1988.
202. Cunningham P. J., Denk C., Sinclair M. Do consumers know how their health plan works?, Health Affairs, 2001, vol. 20, No. 2, pp. 159–166.
203. Tu K., Davis D. Can we alter physician behavior by educational methods? Lessons learned from studies of the management and follow-up of hypertension, Journal of Continuing Education in the Health Professions, 2002, vol. 22, No. 1, pp. 11–22.
204. Davis D. Does CME work? An analysis of the effect of educational activities on physician performance or health care outcomes, The International Journal of Psychiatry in Medicine, 1998, vol. 28, No. 1, pp. 21–39.
205. Giovino G. A., Chaloupka F., Hartman A., Joyce K. G., Chriqui J., Orleans C., Wende K., Tworek C., Barker D., Gibson J. Cigarette smoking prevalence and policies in the 50 states: an era of change – the Robert Wood Johnson Foundation ImpacTeen Tobacco Chart Book, Buffalo, NY: University at Buffalo, State University of New York, 2009, pp. 9–36.
206. Marotta-Wurgler F. Will Increased Disclosure Help? Evaluating the Recommendations of the ALI's “Principles of the Law of Software Contracts”, The University of Chicago Law Review, 2011, pp. 165–186.
207. Hillman R. A., O'Rourke M. Defending Disclosure in Software Licensing, The University of Chicago Law Review, 2011, available at: http://ssrn.com/abstract=1596685
208. Meisel A. A “Dignitary Tort” as a Bridge Between the Idea of Informed Consent and the Law of Informed Consent, Law, Medicine and Health Care, 1988, vol. 16, No. 3–4, pp. 210–218.
209. Amdur R. J., Bankert E. A. Institutional review board: member handbook, 3rd ed., 2011.
210. Zywicki T. J. Institutional review boards as academic bureaucracies: An economic and experiential analysis, Nw. UL Rev., 2007, vol. 101, p. 861.
211. Mueller J. H. Ignorance is neither bliss nor ethical, Nw. UL Rev., 2007, vol. 101, p. 809.
212. Ruppar T. M., Conn V. S., Russell C. L. Medication adherence interventions for older adults: literature review, Research and theory for nursing practice, 2008, vol. 22, No. 2, pp. 114–147.
213. Easterbrook F. H., Fischel D. R. Mandatory disclosure and the protection of investors, Virginia Law Review, 1984, pp. 669–715.
214. Hillman R. A. Online Boilerplate: Would Mandatory Website Disclosure of E-Standard Terms Backfire?, Boilerplate: the foundation of market contracts, ed. O. Ben-Shahar, Cambridge University Press, 2007.
215. Mandell L. Consumer knowledge and understanding of consumer credit, Journal of Consumer Affairs, 1973, vol. 7, No. 1, pp. 23–36.
216. Mann R. J. “Contracting” for Credit, Boilerplate: The Foundation of Market Contracts, ed. О. Ben-Shahar, Cambridge University Press, 2007.
217. Mechanic D. Disadvantage, inequality, and social policy, Health Affairs, 2002, vol. 21, No. 2, pp. 48–59.
218. Jin G. Z., Leslie P. The effect of information on product quality: Evidence from restaurant hygiene grade cards, The Quarterly Journal of Economics, 2003, vol. 118, No. 2, pp. 409–451.
219. Ben-Shahar O. One-Way Contracts: Consumer Protection without Law, European Review of Contract Law, 2010, vol. 6, No. 3, pp. 221–249.
220. Halpern S. D., Ubel P. A., Asch D. A. Harnessing the power of default options to improve health care, The New England journal of medicine, 2007, vol. 357, No. 13, p. 1340.
221. Schneider C. E. The channeling function in family law, Hofstra L. Rev., 1991, vol. 20, p. 495.
222. Thaler R. H., Sunstein C. R. Nudge: Improving decisions about health, wealth, and happiness, New Haven, CT: Yale University Press, 2008.
223. Ben-Shahar O., Schneider C. E. The Failure of Mandated Disclosure, University of Pennsylvania Law Review, 2011, vol. 159, pp. 647–749.

Original publication: https://www.pennlawreview.com/print/?id=299

Citation :

Ben-Shahar O., Schneider C. E. The Failure of Mandated Disclosure, part 4, Actual Problems of Economics and Law, 2017, vol. 11, No. 4, pp. 146–169. DOI: http://dx.doi.org/10.21202/1993-047X.11.2017.4.146-169

Type of article : The scientific article

Date of receipt of the article :
22.12.2016

Date of adoption of the print :
28.03.2017

Date of online accommodation :
25.12.2017